UC Davis Cancer Center
Sacramento, California, 95817, United States
NCT Number: NCT00888407
The purpose of this study is to design an intervention to increase hepatitis B (HBV) screening among Hmong Americans.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Interventional
Not applicable
Sacramento, California, 95817, United States
The investigators will design an intervention to measure the baseline proportion of Hmong adults (ages 18-64) that have been serologically tested for Hepatitis B. Investigators will work with lay health workers to promote serologically testing for Hepatitis B and increase knowledge of Hepatitis B among Hmong adults. The effectiveness of the lay health worker intervention will be evaluated by conducting a randomized, controlled trial among Hmong adults aged 18-64 not previously tested for hepatitis B.
The primary hypothesis is that the proportion of Hmong adults, ages 18-64 reporting serologically testing for Hepatitis B at post-test will be significantly greater in the intervention group than in the control group.
Secondary hypotheses are:
There will be greater increases in knowledge of Hepatitis B and liver cancer in the intervention group than in the control group.
Participants with greater knowledge of hepatitis B and liver cancer at post-test will be more likely to be serologically tested for hepatitis B.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Small group HBV focused discussion with HBV screening resources.
Other names: Hepatitis B screening in Hmong population
Small group session with diet & nutrition focused, topic related resources provided.
Other names: Nutritional education for the Hmong population.
Time frame: September 2006-August 2011
Time frame: September 206 - August 2011
University of California, Davis
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01264705
Adenocarcinoma, Carcinoma
Dallas, Texas, United States
View Trial DetailsNCT06582849
Adnexal Diseases, Anal Cancer
St Louis, Missouri, United States
View Trial DetailsNCT03058289
Bile Duct Cancer, Bile Duct Diseases
Los Angeles, California, United States
View Trial DetailsNCT04028479
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Idaho Falls, Idaho, United States
View Trial Details